BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (MARCH - APRIL 2018)

How To Handle OOS/Deviations and CAPA Still in The Focus of The Regulatory Inspectorates

Sundar Ganesan

Introduction: As standards and regulations go on upgrading, the very basic GMP/GLP Requirements with respect to OOS/Deviations and CAPA are not properly handled in the industry due to various reasons, but regulators expect that following CAPA measures is mandatory. 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.